Carmell Co. (NASDAQ:CTCX) Short Interest Down 33.3% in December

Carmell Co. (NASDAQ:CTCX) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 105,000 shares, a drop of 33.3% from the November 30th total of 157,500 shares. Approximately 0.8% of the company’s shares are short sold. Based on an average trading volume of 5,770,000 shares, the short-interest ratio is currently 0.0 days.

Carmell Stock Performance

CTCX stock opened at $0.31 on Friday. Carmell has a 12-month low of $0.20 and a 12-month high of $4.00. The firm’s 50-day moving average price is $0.29 and its two-hundred day moving average price is $0.72.

Institutional Trading of Carmell

A hedge fund recently bought a new stake in Carmell stock. Warberg Asset Management LLC bought a new stake in shares of Carmell Co. (NASDAQ:CTCX) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 45,000 shares of the company’s stock, valued at approximately $60,000. Warberg Asset Management LLC owned approximately 0.22% of Carmell at the end of the most recent quarter. 24.22% of the stock is owned by institutional investors.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.